Invited Editorials:

Lee YCG and Fitzgerald DB. Pleural biopsy to capture causative microbe: A new piece for the pleural infection jigsaw. CHEST 2018; 154:743-745.

Popowicz N, Idell S and Lee YCG. Pathogenesis of pleural infection: A complex warfare. Respirology 2018; 23:8-9.

Fitzgerald DB and Lee YCG. Pleural Infection: To drain or not to drain? Respirology 2017; in press.

Creaney J and Lee YCG. Diagnoses (not Diagnosis) of a pleural effusion – time to think concurrent etiologies. Ann Am Thorac Soc 2016; 13:1003-4.

Porcel JM, Stathopoulos G and Lee YCG.  Advances and controversies in pleural diseases.   J Thorac Dis 2015; 7:961-3. [PDF]

Lee YCG.  Surgical resection of malignant pleural mesothelioma: an evidence-free practice. [Commentary].   Lancet 2014;384(9948):1080-1. [PDF]

Brims FJ, Lee YCG and Creaney J.  The continual search for ideal biomarkers for mesothelioma: the hurdles. [Editorial].   J Thorac Dis 2013; 5:364-366. [PDF]

Lee YCG and Waterer GW.  The need for translational research in respiratory medicine. [Editorial]   Trans Resp Med 2013; 1:9. [PDF] 

Lee YCG.  Respirology: a thank you note from the outgoing editor. [Editorial]   Respirology 2011; 16:1017. [PDF]

Lee YCG and Fysh ET.  Indwelling pleural catheters: Changing the paradigm of malignant effusion management. [Editorial]   J Thorac Oncol 2011; 6: 655-657. [PDF]

Lee YCG.  Respirology: To unpathed waters and undreamed shores. [Editorial]   Respirology 2009; 14: 622. [PDF]

Lee YCG and Wilkosz S.  Malignant pleural effusions: Fixing the leaky faucet. [Editorial]   Am J Respir Crit Care Med 2008; 178: 3-5. [PDF] 

Davies HE, Lee YCG and Davies RJO.   Pleurodesis for malignant pleural effusion: talc, toxicity and what next?  [Editorial]   Thorax 2008; 63: 572-574. [PDF]

Lee YCG.  Hunting for a pleural fluid test for mesothelioma: Is soluble mesothelin the answer? [Editorial]  Thorax 2007; 62:561-562. [PDF]

Lee YCGOngoing search for effective intrapleural therapy for empyema: Is streptokinase the answer?  [Editorial]   Am J Respir Crit Care Med 2004; 170: 1-2. [PDF]

Lee YCG and Light RW.  How does pleurodesis affect lung function? [Editorial]   J Respir Dis 2001; 22: 706. 


Invited Reviews:

Thomas R, Roy B, Maldonado F and Lee YCG. Management of malignant pleural effusions – What is new. Semin Respir Crit Care Med 2019; in press.

Gregory P, Rahman NM and Lee YCG. Pleural infection: from Osler’s death to modern day management. Postgrad Med J 2019; Provisionally accepted pending minor revision.  

Louw A, Badiei A, Creaney J, Chai MS and Lee YCG. Advances in pathological diagnosis of mesothelioma: What pulmonologists should know. Curr Opin Pulm Med. 2019; 25:354-361.

Sidhu C, Louw A, Brims F, Creaney J and Lee YCG. Malignant pleural mesothelioma: An Update for Pulmonologists. Curr Pulm Rpt 2019; 8:40-49.

Koegelenberg CFN, Shaw AJ, Irusen EM and Lee YCG. Contemporary best practice in the management of malignant pleural effusion. Ther Adv Respir Dis 2018; 12:1753466618785098. 

Chan KP, Fitzgerald DB and Lee YCG. Emerging concepts in pleural infection. Curr Opin Pulm Med 2018; 24:367-373. 

Badiei A, Chan KP, Lee YCG and Waterer GW. Corticosteroids in lung and pleural infections. Curr Pulm Rpts 2018; 7:19-27.

Komissarov A, Rahman NA, Lee YCG, Florova G, Shetty S, Idell R, Ikebe M, Tucker TA and Idell S. Fibrin turnover and pleural organization: Bench to bedside.  Am J Physiol Lung Cell Mol Physiol 2018; 314:L757-L768.

Fitzgerald DB, Koegelenberg CF, Yasufuku K and Lee YCG. Surgical and non-surgical management of malignant pleural effusions. Expert Rev Respir Med 2018; 12:15-26.

195. Cooley J, Lee YCG and Gupta N. Spontaneous pneumothorax in diffuse cystic lung diseases Curr Opin Pulm Med 2017; 23: 323-333.

Porcel JM, Lui MMS, Lerner A, Davies HE, Feller-Kopman D and Lee YCG.  Comparing management approaches to malignant pleural effusions  Expert Rev Respir Med 2017; 11: 273-284.

Muruganadan S, Kumar S and Lee YCG. Blood patch for pneumothorax: a literature review.  Curr Pulm Rpt 2017; 6:30-38.  

Muruganandan S, Jeffery E, McIntyre C, Lee YCG. Nutrition, exercise, and complementary medicine: potential role in mesothelioma. Curr Pulm Rpt 2016; 5: 20-27.

Lee YCG, Idell S and Stathopoulos GT. Translational research in pleural infection and beyond. CHEST 2016; 150: 1361-1370.   

Lui MMS, Fitzgerald D and Lee YCG. Phenotyping malignant pleural effusions. Curr Opin Pulm Med 2016; 22:350-355.

Lui MMS, Thomas R and Lee YCG. Complications in the use of indwelling pleural catheters and their best management. BMJ Open Respir Res 2016; 3:e000123.

Bintcliffe O, Lee YCG, Maskell NA and Rahman NM. Benign non-infective pleural effusions and their management. Eur Respir Rev 2015; 3: 578-88.

Porcel JM, Azzopardi M, Koegelenberg CF, Maldonado F, Rahman NM and Lee YCG. Diagnosis of pleural effusions.  Expert Rev Respir Med 2015; 9:801-815.

Bintcliffe OJ, Hallifax RJ, Edey A, Fellor-Kopman D, Lee YCG, Marquette CH, Tschopp JM, West D, Rahman NM and Maskell NA.  Spontaneous pneumothorax – Time to rethink management?    Lancet Respir Med 2015; 3:578-88. [PDF]

Thomas R, Jenkins S, Eastwood PR, Lee YCG and Singh B.  Physiology of breathlessness associated with pleural effusions.  Curr Opin Pulm Med 2015; 21: 338-345. 

Piccolo F, Popowicz N, Wong D, and Lee YCG.   Intrapleural Tissue Plasminogen Activator and Deoxyribonuclease Therapy for Pleural Infection.   J Thorac Dis 2015; 7:999-1008. [PDF]

Azzopardi M, Porcel JM, Koegelenberg CFN, Lee YCG and Fysh ETCurrrent controversies in the management of malignant pleural effusions.   Semin Respir Crit Care Med 2014; 35:723-31.

Robinson C, Solin J, Lee YCG, Lake RA, Lesterhuis WJ.  Mouse models of mesothelioma: strengths, limitations and clinical translation.   Lung Cancer Manag 2014; 3: 397-410. 

Thomas R, Francis R, Davies HEand Lee YCG.   Interventional therapies for malignant pleural effusions: the present and future.   Respirology 2014; 19:809-822. [PDF]  

Yap KH, Phillips MJ and Lee YCG.   Medical thoracoscopy: rigid thoracoscopy or flexi-rigid pleuroscopy?  Curr Opin Pulm Med 2014; 20:358-65. [PDF]

Davies HE and Lee YCGManagement of malignant pleural effusions: questions that need answers.   Curr Opin Pulm Med 2013; 19:374-379. [PDF]

Boshuizen R, Thomas R and Lee YCGAdvantages of indwelling pleural catheters for management of malignant pleural effusions.   Curr Respir Care Rep 2013; 2:93-99. [PDF]   

Thomas R and Lee YCGCauses and management of common benign pleural effusions.   Thorac Surg Clin 2013; 23:25-42. [PDF]   

Eastwood PR, Naughton M, Calvery P, Zeng G, Beasley R, Robinson BW and Lee YCG. How to write research papers and grants: 2011 Asian Pacific Society of Respirology Annual Scientific Meeting Postgraduate Session.   Respirology 2012; 17:792-801. [PDF]

Tobin C and Lee YCG.  Pleural infection – what we need to know but don’t.  Curr Opin Pulm Med 2012; 18:321-325. [PDF]

Rosenstengel A and Lee YCG.  Pleural infection – current diagnosis and management.  J Thorac Dis 2012; 4:186-193. [PDF]

Tobin C, Porcel JM, Wrightson JM, Waterer GW, Light RW and Lee YCG.   Diagnosis of pleural infection: State-of-the-Art.  Curr Respir Care Rep 2012; 1:101-110. [PDF]

Davies HE, Rosenstengel A and Lee YCG. The diminishing role of surgery in pleural diseases.  Curr Opin Pulm Med 2011; 17: 247-254. [PDF]

Sriram KB, Relan V, Clarke BE, Duhig EE, Yang IA, Bowman R, Lee YCG and Fong K.   Diagnostic molecular biomarkers for malignant pleural effusions.   Future Oncol 2011; 7: 737-52. [PDF]

Lisboa T, Waterer GW and Lee YCG.   Pleural infection: Changing bacteriology and its implications.  Respirology 2011; 16: 598-603[PDF]

Tung A, Porcel JM, Bilaceroglu S, Creaney J and Lee YCG.   Biomarkers in pleural diseases.  US Respiratory Diseases 2011; 7: 26-31. [PDF]

Fysh ET, Smith NA and Lee YCG.  Optimal chest drain size: the rise of the small-bore pleural catheter.   Semin Respir Crit Care Med 2010; 31: 760-768.

Davies HE, Steer H, Fysh E and Lee YCGDiagnosis and management of malignant pleural effusions.   Minerva Pneumologica 2010; 49: 237-52. 

Hooper CE, Lee YCG and Maskell NA.  Setting up a specialist pleural disease service.   Respirology 2010; 15:1028-1036. [PDF]

Lee YCG.  The undiagnosed pleural effusion.   UpToDate (www.uptodate.com); 2010 version.

Brims FJ, Lansley SM, Waterer GW and Lee YCG.   Empyema Thoracic – new insights into an old disease.  Eur Respir Rev 2010; 19: 220-228. [PDF]

Wrightson JM, Fysh E, Maskell NA and Lee YCG.   Risk Reduction in Pleural Procedures: Sonography, Simulation and Supervision.  Curr Opin Pulm Med 2010; 16: 340-350. [PDF]

Brims FJ, Davies HE and Lee YCG.   Respiratory chest pain: diagnosis and management.  Med Clinic N Am 2010; 94:217-232. [PDF]

Heffner JE, Holgate ST, Chung KF, Niederman MS, Daley CL, Jett JR, Wells AU, Tapson VF, Stradling JR, Light RW, Hansell DM, Pronovost PJ and Lee YCG.   The road ahead to respiratory health – experts chart future research directions.   Respirology 2009; 14: 625-636. [PDF]

Hooper C, Lee YCG and Maskell NA.   Interferon Gamma Release Assays (IGRAs) for the diagnosis of TB pleural effusions: Hype or real hope?  Curr Opin Pulm Med 2009; 15: 358-365. [PDF]

Davies HE, Lee YCG and Davies RJO.   Authors reply: Pleurodesis by talc poudrage under simple medical thoracoscopy in malignant pleural effusion. An international opinion. [Letter]   Thorax 2009; 64: 274. [PDF]

Davies HE, Musk AW and Lee YCG.  Prophylactic radiotherapy to pleural puncture sites in mesothelioma: the controversy continues.   Curr Opin Pulm Med 2008; 14: 326-330.

Lee YCGPleural fluid pH: the acid test.  Intl Pleural Newsl 2008; 6: 16-17.

Lee YCG and Sahn SA.  The undiagnosed pleural effusion.   UpToDate; 2008: version 16.1 (www.uptodate.com).  Last update Feb 7, 2008.  

Davies HE and Lee YCG.  Indwelling tunnelled pleural catheters. Plevra Bülteni 2008; 1: 8-13.   [Turkish]   www.toraks.org.tr

Scherpereel A and Lee YCG.  Biomarkers for mesothelioma. Curr Opin Pulm Med 2007; 13:339-343.

Hague J and Lee YCG.  Mesothelioma.  Student BMJ 2007; 15: 341.

Beasley R and Lee YCG. Respirology Year-In-Review 2006: Clinical Science. Respirology 2007; 12: 6-15.

West SD and Lee YCGCurrent management of malignant pleural mesothelioma. Clin Chest Med 2006; 27: 335-354.

Mutsaers SE, Kalomenidis I, Wilson NA and Lee YCGGrowth factors in pleural fibrosis. Curr Opin Pulm Med 2006; 12:251-258.

Lee YCG and Beasley R. Respirology Year-In-Review 2005: Clinical Science. Respirology 2006; 11: 124-130.

Lee YCGPleural disease: A forgotten frontier in respiratory research. [Editorial]   Respirology 2006; 11: 4-5.

Dalbeth N and Lee YCGLymphocytes in pleural effusions.  Curr Opin Pulm Med 2005; 11: 334-339.

Kalomenidis I, Light RW and Lee YCGTransforming Growth Factor-beta: A potential new agent for pleurodesis.  Drug Design Reviews - Online 2005; 2: 47-51.

Lee YCG.  SV40 as a causative agent in mesothelioma – a new twist to the story. Thorax 2005; 60:16.

Lee YCG and Light RW.  Management of malignant pleural effusions. Respirology 2004; 9: 148-156.

West SD, Davies RJO and Lee YCGPleurodeses for malignant pleural effusions: current controversies and variations in practices.  Curr Opin Pulm Med 2004; 10: 305-310.

Lee YCG and Davies RJO.  Management of pleural effusions in acute medical settings: A practical guide.  CPD Journal of Acute Medicine 2004; 3: 26-32.

Lee YCG and Light RW.  Adenosine deaminase for lymphocytic pleural effusions.  Intl Pleural Newsl 2004; 2: 5-6.

Chapman SJ, Cookson WO, Musk AW and Lee YCGBenign asbestos pleural diseases Curr Opin Pulm Med 2003; 9: 266-271.

Grove CS and Lee YCGVascular Endothelial Growth Factor: the key mediator in pleural effusion formation.  Curr Opin Pulm Med 2002; 8: 294-301.

Lee YCG and Lane KB.  The many faces of Transforming Growth Factor-beta in pleural diseases  Curr Opin Pulm Med 2001; 7: 173-179.

Lee YCG, Rodriguez RM, Lane KB and Light RW.   Pleurodesis for recurrent pleural effusions in the new millennium.  Recent Advances and Research Updates 2001; 2: 81-89.

Lee YCG, Light RW and Musk AW.  Management of malignant pleural mesothelioma: A critical review.  Curr Opin Pulm Med 2000; 6:267-274.